Search

everythinglearnresearchcommunity

for

Search:↓

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

The combined therapy improved symptoms in PCOS patients.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

PCOS treatment should be personalized based on individual symptoms and health goals.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

Apigenin and ellagic acid may help manage PCOS symptoms.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.